Chong Kun Dang Pharmaceutical

This study tested whether CertiroBell (everolimus) works better than mycophenolate mofetil at preventing organ rejection, graft loss, or death in 150 adults who received a liver transplant from a living donor. Participants took one of the two drugs for up to a year. The goal was …

This study looked at how a tacrolimus tablet (TacroBell) works in people who received a kidney transplant. The goal was to measure drug levels in the blood and see how well patients tolerated it. 128 adults who were getting a kidney from a deceased or living donor took part. The …

This study tested two similar immunosuppressant drugs, MYREPTIC-N® and MY-REPT®, in 158 adults who had a kidney transplant at least a year ago. The goal was to see how well each drug prevented organ rejection, graft loss, or death. Participants continued their usual anti-rejectio…

This study tested a new treatment called CKD-981 to see if it can safely and temporarily ease knee pain in people with osteoarthritis. About 100 adults aged 40 to 80 with moderate knee pain took part. The treatment was compared to a fake procedure (sham) to measure its true effec…

This early-stage trial tests a new drug called CKD-846 in 32 healthy men with benign prostate hypertrophy (enlarged prostate). The main goal is to see how the drug moves through the body and if it is safe. Participants must be men aged 19 to 55 with a healthy weight.

This study looked at how a new drug called CKD-508 interacts with two other medicines (midazolam and rosuvastatin) in 24 healthy adult men. The goal was to measure drug levels in the blood, not to treat any disease. It helps researchers understand safe dosing for future studies.

This early-stage trial tested the safety and how the body handles CKD-508, a new drug, in 44 healthy adults. Participants received either the drug or a placebo once daily. The study measured side effects, drug levels in the blood, and changes in cholesterol-related markers. Since…

This early-stage study tested a new drug called CKD-846 in 31 healthy men to see how the body processes it and if it is safe. The goal was to gather information, not to treat the condition. Participants were healthy men aged 19 to 55 who agreed to use contraception.

This study looked at how a new drug combination called CKD-383 is absorbed and processed in the body. It involved 31 healthy adults who took the drug either as a single combined pill or as separate pills. The goal was to compare the two ways of taking the medication, not to treat…

This early-stage study looked at how a new combination diabetes drug, CKD-383, is processed by the body and whether it is safe. Thirty healthy adults took the drug as two tablets together or separately in a random order. The goal was to compare the two ways of taking the medicati…

This study looked at how a new combination diabetes drug, CKD-383, moves through the body compared to taking the individual drugs separately. It involved 30 healthy adults who received a single dose of each treatment in a random order. The goal was to measure drug levels and chec…